Sun Pharma Advanced Research Company Limited (NSE:SPARC) — Market Cap & Net Worth

$850.97 Million USD  · Rs78.69 Billion INR  · Rank #9786

Market Cap & Net Worth: Sun Pharma Advanced Research Company Limited (SPARC)

Sun Pharma Advanced Research Company Limited (NSE:SPARC) has a market capitalization of $850.97 Million (Rs78.69 Billion) as of June 19, 2026. Listed on the NSE stock exchange, this India-based company holds position #9786 globally and #483 in its home market, demonstrating a 17.75% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sun Pharma Advanced Research Company Limited's stock price Rs242.47 by its total outstanding shares 324521588 (324.52 Million). Review Sun Pharma Advanced Research Company Lim total liabilities to assess the company's total debt and financial obligations.

Sun Pharma Advanced Research Company Limited Market Cap History: 2015 to 2026

Sun Pharma Advanced Research Company Limited's market capitalization history from 2015 to 2026. Data shows change from $1.19 Billion to $850.97 Million (-4.25% CAGR).

Index Memberships

Sun Pharma Advanced Research Company Limited is a constituent of 4 market indices:

Index Total Market Cap Weight (%) Rank by Market Cap
NIFTY 500
NIFTY500
$3.15 Trillion 0.03% #362 of 500
NIFTY MIDSMALLCAP 400
NIFTYMIDSML400
$1.15 Trillion 0.07% #263 of 400
NIFTY TOTAL MARKET
NIFTYTOTALMKT
$3.24 Trillion 0.03% #392 of 750
NIFTY SMALLCAP 250
NISM250
$390.05 Billion 0.22% #175 of 250

Weight: Sun Pharma Advanced Research Company Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Sun Pharma Advanced Research Company Limited Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Sun Pharma Advanced Research Company Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

0.66x

Sun Pharma Advanced Research Company Limited's market cap is 0.66 times its annual revenue

Industry average: 0.53x Higher than industry average

Latest Price to Earnings (P/E) Ratio

N/A

P/E ratio not applicable due to negative or zero earnings

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
2016 $1.07 Billion $1.61 Billion -$699.92 Million 0.66x N/A
2017 $1.78 Billion $1.81 Billion -$1.20 Billion 0.98x N/A
2018 $659.98 Million $782.59 Million -$1.97 Billion 0.84x N/A
2019 $548.20 Million $1.83 Billion -$1.45 Billion 0.30x N/A
2020 $679.98 Million $768.14 Million -$3.12 Billion 0.89x N/A
2021 $980.23 Million $2.53 Billion -$1.51 Billion 0.39x N/A
2022 $732.10 Million $1.37 Billion -$2.03 Billion 0.53x N/A
2023 $1.01 Billion $2.39 Billion -$2.23 Billion 0.42x N/A
2024 $703.85 Million $755.45 Million -$3.87 Billion 0.93x N/A
2025 $471.86 Million $717.70 Million -$3.43 Billion 0.66x N/A

Competitor Companies of SPARC by Market Capitalization

Companies near Sun Pharma Advanced Research Company Limited in the global market cap rankings as of June 19, 2026.

Key companies related to Sun Pharma Advanced Research Company Limited by market ranking:

  • Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #515 globally with a market cap of $52.60 Billion USD.
  • GALDERMA GROUP AG (NYSE:GALDY): Ranked #555 globally with a market cap of $48.78 Billion USD.
  • Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #601 globally with a market cap of $45.20 Billion USD ( CN¥308.87 Billion CNY).
  • Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #627 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#515 Takeda Pharmaceutical Co Ltd ADR NYSE:TAK $52.60 Billion $16.65
#555 GALDERMA GROUP AG NYSE:GALDY $48.78 Billion $42.94
#601 Jiangsu Hengrui Medicine Co Ltd SHG:600276 $45.20 Billion CN¥48.42
#627 Takeda Pharmaceutical Company Limited F:TKDA $43.60 Billion €13.30

Sun Pharma Advanced Research Company Limited Historical Marketcap From 2015 to 2026

Between 2015 and today, Sun Pharma Advanced Research Company Limited's market cap moved from $1.19 Billion to $ 850.97 Million, with a yearly change of -4.25%.

Year Market Cap Change (%)
2026 Rs850.97 Million +80.34%
2025 Rs471.86 Million -32.96%
2024 Rs703.85 Million -30.07%
2023 Rs1.01 Billion +37.49%
2022 Rs732.10 Million -25.31%
2021 Rs980.23 Million +44.15%
2020 Rs679.98 Million +24.04%
2019 Rs548.20 Million -16.94%
2018 Rs659.98 Million -62.96%
2017 Rs1.78 Billion +66.57%
2016 Rs1.07 Billion -10.29%
2015 Rs1.19 Billion --

End of Day Market Cap According to Different Sources

On Jun 19th, 2026 the market cap of Sun Pharma Advanced Research Company Limited was reported to be:

Source Market Cap
Yahoo Finance $850.97 Million USD
MoneyControl $850.97 Million USD
MarketWatch $850.97 Million USD
marketcap.company $850.97 Million USD
Reuters $850.97 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Sun Pharma Advanced Research Company Limited

NSE:SPARC India Drug Manufacturers - Specialty & Generic
Market Cap
$850.97 Million
Rs78.69 Billion INR
Market Cap Rank
#9786 Global
#483 in India
Share Price
Rs242.47
Change (1 day)
+1.19%
52-Week Range
Rs108.71 - Rs242.47
All Time High
Rs519.35
About

Sun Pharma Advanced Research Company Limited, a clinical-stage biopharmaceutical company, engages in the research and development of pharmaceutical products in India and internationally. It develops products with a therapeutic focus on oncology and immunology. The company is also developing Vodobatinib (SCO-088), a BCR-ABL inhibitor, for the treatment of refractory chronic myelogenous leukemia th… Read more